Skip to main content

Articles

Page 5 of 342

  1. Tobacco use is one of the main risk factors for Lung Cancer (LC) development. However, about 10–20% of those diagnosed with the disease are never-smokers. For Non-Small Cell Lung Cancer (NSCLC) there are clear...

    Authors: Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina…
    Citation: BMC Cancer 2024 24:951
  2. To investigate the impact of response to induction chemotherapy (IC) on survival outcomes in patients with locally advanced nasopharyngeal carcinoma (LANPC) and evaluate the efficacy of adding nimotuzumab to c...

    Authors: Lin-Feng Guo, Ming-Yue Rao, Yi-Feng Yu, Qin Lin and San-Gang Wu
    Citation: BMC Cancer 2024 24:950
  3. Structured exercise has an important role in mitigating the extensive side effects caused by ongoing prostate cancer treatments, specifically androgen deprivation therapy (ADT) and radiation therapy (RT). Litt...

    Authors: Kira Murphy, Bróna Kehoe, Suzanne Denieffe, Aisling McGrath, Dayle Hacking, Ciaran M. Fairman and Michael Harrison
    Citation: BMC Cancer 2024 24:949
  4. Hepatoid adenocarcinoma of the lung (HAL) is a distinctly uncommon subtype of lung adenocarcinoma (LAC), characterized by hepatoid features and an alarmingly low 5-year survival rate of approximately 8%. The s...

    Authors: Huijing Deng, Luyao Wang, Zewei Li, Tao Zhan and Liu Huang
    Citation: BMC Cancer 2024 24:948
  5. Although immunotherapy shows tremendous potential in the treatment of bladder cancer (BLCA), the overall prognosis and response rates to immunotherapy in BLCA remain suboptimal.

    Authors: Renyu Liu, Ting Yang, Jinyu Huang, Zicheng Xiao, Jinhui Liu, Zhenghao Li and Shiyu Tong
    Citation: BMC Cancer 2024 24:947
  6. Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer-related death in men in Algeria. Little is known about the characteristics of lung cancer in Algeria. This study aimed to deter...

    Authors: Mohamed Lahmadi, Leila Beddar, Souad Ketit, Tarek Makhbouche, Narriman Laouar and Taha Filali
    Citation: BMC Cancer 2024 24:946
  7. Many patients undergo dose reduction or early termination of chemotherapy to reduce chemoradiotherapy-related toxicity, which may increase their risk of survival. However, this strategy may result in underdosi...

    Authors: Li Jiang, Jie Zhu, Xue Chen, Yi Wang, Lei Wu, Gang Wan, Yongtao Han, Xuefeng Leng, Jun Zhang, Lin Peng and Qifeng Wang
    Citation: BMC Cancer 2024 24:945
  8. Currently, family with sequence similarity 65 member A (FAM65A) is reported as a pivotal regulator in various cancers. However, the effect of FAM65A in lung squamous cell carcinoma (LSCC) is still unclear, the...

    Authors: Fangjun Chen, Peng Ren, Rui Xu, Jin Zhang, Chaoyang Liang and Guangliang Qiang
    Citation: BMC Cancer 2024 24:944
  9. Paediatric solid tumours, both benign and malignant, present significant health challenges, particularly in Sub-Saharan Africa where comprehensive data is limited. This study aims to elucidate the prevalence, ...

    Authors: Chisom Adaobi Nri-Ezedi, Thomas Obiajulu Ulasi, Felix Emeka Menkiti, Chinedu Onwuka Ndukwe, Chinelo M. Igwenagu and Frank Chinedu Akpuaka
    Citation: BMC Cancer 2024 24:943
  10. Lung cancer is the third most common cancer in the UK and the leading cause of cancer mortality globally. NHS England guidance for optimum lung cancer care recommends management and treatment by a specialist t...

    Authors: Daisy McInnerney, Samantha L. Quaife, Samuel Cooke, Lucy Mitchinson, Zara Pogson, William Ricketts, Adam Januszewski, Anna Lerner, Dawn Skinner, Sarah Civello, Ros Kane, Ava Harding-Bell, Lynn Calman, Peter Selby, Michael D. Peake and David Nelson
    Citation: BMC Cancer 2024 24:942
  11. Advanced pancreatic adenocarcinoma lacks effective treatment options, and systemic gemcitabine-based chemotherapy offers only marginal survival benefits at the cost of significant toxicities and adverse events...

    Authors: Changjing Huang, Chien-shan Cheng, Yehua Shen, Hao Chen, Junhua Lin, Yongqiang Hua, Lanyun Feng, Caijun Wu, Peng Wang, Zhen Chen and Zhiqiang Meng
    Citation: BMC Cancer 2024 24:941
  12. Stereotactic irradiation has become the mainstay treatment for brain metastases (BM), and whole-brain radiotherapy (WBRT) is often used for symptom palliation. However, the survival time of patients with BM un...

    Authors: Toshiaki Hirose, Shoichi Deguchi, Kazuaki Yasui, Minoru Inoue, Tsuyoshi Onoe, Hirofumi Ogawa, Hirofumi Asakura, Koichi Mitsuya, Hideyuki Harada, Shigeyuki Murayama, Nakamasa Hayashi, Tetsuo Nishimura and Ryuta Saito
    Citation: BMC Cancer 2024 24:940
  13. The randomized, dose-optimization, open-label ReDOS study in US patients with metastatic colorectal cancer (CRC) showed that, compared with a standard dosing approach, initiating regorafenib at 80 mg/day and e...

    Authors: Tanios Bekaii-Saab, Nasreen Khan, Helene Ostojic, XiaoLong Jiao, Guifang Chen, Wenlong Lin and Amanda Bruno
    Citation: BMC Cancer 2024 24:939
  14. Sarcomatoid carcinoma of the lung is a rare histological type of non-small cell lung cancer with a poor prognosis. We aimed to investigate the clinicopathological characteristics and prognostic factors of surg...

    Authors: Kaoru Kaseda, Keisuke Asakura, Yasushi Shintani, Jiro Okami, Shinichi Toyooka, Yukio Sato, Shun-Ichi Watanabe, Masayuki Chida, Hidemi Suzuki, Etsuo Miyaoka, Ichiro Yoshino and Hiroshi Date
    Citation: BMC Cancer 2024 24:938
  15. Neuropeptide Y is a neurotransmitter in the nervous system and belongs to the orexigenic system that increases appetite. Its excessive secretion leads to obesity. Leptin is a pro-inflammatory adipokine (produc...

    Authors: Małgorzata Frąk, Anna Grenda, Paweł Krawczyk, Barbara Kuźnar-Kamińska, Paweł Pazdrowski, Karolina Kędra, Izabela Chmielewska and Janusz Milanowski
    Citation: BMC Cancer 2024 24:937
  16. To evaluate the dosimetric characteristics of ZAP-X stereotactic radiosurgery (SRS) for single brain metastasis by comparing with two mature SRS platforms.

    Authors: Jinyuan Wang, Qingzeng Zheng, Yanping Wang, Chengcheng Wang, Shouping Xu, Zhongjian Ju, Longsheng Pan, Jingmin Bai, Yunmo Liu, Baolin Qu and Xiangkun Dai
    Citation: BMC Cancer 2024 24:936
  17. Lymph node (LN) metastasis is an established prognostic factor for patients with surgically resected ampulla of Vater (AoV) cancer. The standard procedure for radical resection, including removal of regional L...

    Authors: So Jeong Yoon, Seung Soo Hong, Kee-Taek Jang, So Kyung Yoon, Hongbeom Kim, Sang Hyun Shin, Jin Seok Heo, Chang Moo Kang, Kyung Sik Kim, Ho Kyoung Hwang and In Woong Han
    Citation: BMC Cancer 2024 24:935
  18. Due to the close proximity of the prostate and rectum, rectal toxicity remains a major problem in patient treated by radiotherapy for prostate adenocarcinoma. One method of increasing the distance between the ...

    Authors: G. Janoray, E. Bruguière, J. Mazurier, P. Dudouet, J. Guillotreau, C. Tollon, P. Labarthe, P. Seguin and I. Latorzeff
    Citation: BMC Cancer 2024 24:934
  19. Cervical cancer remains a significant but preventable threat to women’s health throughout much of the developing world, including Uganda. Cervical cancer screening and timely treatment of pre-cancerous lesions...

    Authors: Kathryn Bouskill, Glenn J. Wagner, Mahlet Gizaw, Joseph KB Matovu, Margrethe Juncker, Eve Namisango, Sylvia Nakami, Jolly Beyeza-Kashesya, Emmanuel Luyirika and Rhoda K. Wanyenze
    Citation: BMC Cancer 2024 24:933
  20. Esophageal carcinoma is a growing concern in regions that have a high incidence of human papillomavirus (HPV) infection such as East Africa. HPV, particularly the high-risk genotypes, is increasingly recognize...

    Authors: Lilian M. Ndemela, Oscar M. Ottoman, Heaven D. Chitemo, Caroline Anold Minja, Peter F. Rambau and Benson R. Kidenya
    Citation: BMC Cancer 2024 24:932
  21. Despite the recent advances in cancer treatment, the therapeutic options for patients with biliary tract cancer are still very limited and the prognosis very poor. More than 50% of newly diagnosed patients wit...

    Authors: Constantin Schmidt, Antonia Zapf, Ann-Kathrin Ozga, Ali Canbay, Ulrike Denzer, Enrico N. De Toni, Ansgar W. Lohse, Kornelius Schulze, Thomas Rösch, Alexander Stein, Henning Wege and Johann von Felden
    Citation: BMC Cancer 2024 24:931
  22. Betel quid chewing, prevalent in Southeast Asia and South Asia, involves components such as betel leaf, areca nut, slaked lime, and sometimes tobacco. This study aims to assess buccal mucosa changes in betel q...

    Authors: Hamrish Kumar Rajakumar, Varsha Coimbatore Sathyabal, Kolsamma Nasrin Jabarulla and Pushpa Balamurugesan
    Citation: BMC Cancer 2024 24:930
  23. In this study, we aimed to establish nomograms to predict the microvascular invasion (MVI) and early recurrence in patients with small hepatocellular carcinoma (SHCC), thereby guiding individualized treatment ...

    Authors: Xi Wang, Xinqun Chai, Ji Zhang, Ruiya Tang and Qinjunjie Chen
    Citation: BMC Cancer 2024 24:929
  24. Osteosarcoma (OS) is one of the most common primary malignant tumors of bone in children, which develops from osteoblasts and typically occurs during the rapid growth phase of the bone. Recently, Super-Enhance...

    Authors: Di Wu, Hongli Yin, Chun Yang, Zimu Zhang, Fang Fang, Jianwei Wang, Xiaolu Li, Yi Xie, Xiaohan Hu, Ran Zhuo, Yanling Chen, Juanjuan Yu, Tiandan Li, Gen Li and Jian Pan
    Citation: BMC Cancer 2024 24:928
  25. This study aims to explore ADH4 expression in hepatocellular carcinoma (HCC), its prognostic impact, and its immune correlation to provide novel insights into HCC prognostication and treatment.

    Authors: Ling Li, Yong-ta Huang, Li-ting Wang, Xiao-ling Wang, Zhen-yu Chen, Shao-lan Jiang, Qiu-ling Zeng, Hui-pin Huang and Xiao-long Li
    Citation: BMC Cancer 2024 24:927
  26. As the most malignant tumor of the female reproductive system, ovarian cancer (OC) has garnered increasing attention. The Warburg effect, driven by glycolysis, accounts for tumor cell proliferation under aerob...

    Authors: Jinting Ji, Fangfang Bi, Xiaocui Zhang, Zhiming Zhang, Yichi Xie and Qing Yang
    Citation: BMC Cancer 2024 24:926
  27. Lung adenocarcinoma is a high-mortality rate cancer. Within this category, Lung mucinous adenocarcinoma (LMAC) is a rare and distinct subtype of lung adenocarcinoma necessitating further investigation. The stu...

    Authors: Qi-Yue Ge, Chao Zheng, Guo-Chao Zhang, Zhuang-Zhuang Cong, Jing Luo, Yang Xu, Chang-Yong Wang, Chao Luo, Wei Wei, Zhi-Hui Yang, Ming-Ze Li, Yu-Heng Wu, Yu-Yang Wang, Qi Xue and Yi Shen
    Citation: BMC Cancer 2024 24:925
  28. With advances in endoscopic submucosal dissection (ESD) technique, an increasing number of the Chinese population are being diagnosed with early gastric cancers (EGCs) at gastric angulus. However, the relation...

    Authors: Qiaoyan Wu, Tongyu Li, Yangyang Cui, Haizhong Jiang, Yangbo Fu, Qi Jiang and Xiaoyun Ding
    Citation: BMC Cancer 2024 24:924
  29. Lenvatinib, a multitarget kinase inhibitor, has been proven to be effective in the treatment of advanced hepatocellular carcinoma. It has been previously demonstrated that tumour associated macrophages (TAMs) ...

    Authors: Peng Sun, Zhenfeng Li, Zaojun Yan, Zhaofeng Wang, Peng Zheng, Mingliang Wang, Xu Chang, Zihao Liu, Jianxin Zhang, Huiyong Wu, Wenbo Shao, Dewen Xue and Jinming Yu
    Citation: BMC Cancer 2024 24:922
  30. The two major causes of cancer-related deaths among women in Ghana are breast cancer (BC) and cervical cancer (CC). These types of cancers typically do not show any symptoms until they have progressed. Therefo...

    Authors: Emmanuel Anongeba Anaba, Stanley Kofi Alor, Caroline Dinam Badzi, Charlotte Bongfen Mbuwir, Berienis Muki and Agani Afaya
    Citation: BMC Cancer 2024 24:920
  31. The purpose of this multicenter retrospective study was to analyze the clinical and radiological effects of bevacizumab (BV) on radionecrosis (RN) that developed after stereotactic radiotherapy (SRT) for brain...

    Authors: Teuta Zoto Mustafayev, Menekse Turna, Yasemin Bolukbasi, Evrim Tezcanli, Yildiz Guney, Fazilet Oner Dincbas, Beste Melek Atasoy, Gamze Ugurluer, Hale Basak Caglar, Banu Atalar and Enis Ozyar
    Citation: BMC Cancer 2024 24:918
  32. The femur is a common site for Multiple Myeloma (MM) involvement. This study explores the impact of preventive surgery for anticipated femoral pathological fractures (IFF), based on Mirels classification, vers...

    Authors: Oded Hershkovich, Mojahed Sakhnini, Gal Barkay, Boaz Liberman, Alon Friedlander and Raphael Lotan
    Citation: BMC Cancer 2024 24:917
  33. Colorectal cancer (CRC) ranks as the third most common malignancies in the world, and periodic examination of the patient is advantageous in reducing the mortality of CRC. The first blood-based Septin9 gene me...

    Authors: Youming Wu, Yongqing Tong, Haitao Zhang, Yun Li, Xu Zhu, Ming Li, Lili Qiu, Wenlan Liu, Siqing Mei, Yu Mao, Yanhua Cao, Caiyan Su, Wentao Yu, Junli Wang, Taizhong Wang, Zhongyuan Zhu…
    Citation: BMC Cancer 2024 24:916
  34. This investigation aims to elucidate the treatment status of advanced HR+/HER2- breast cancer patients in Hunan Province of Central Southern China from November 2021 to December 2022.

    Authors: Zhe-Yu Hu, Binliang Liu, Ning Xie, Xiaohong Yang, Liping Liu, Huawu Xiao, Jing Li, Hui Wu, Jianxiang Gao, Jun Lu, Xuming Hu, Min Cao, Zhengrong Shui, Can Tian and Quchang Ouyang
    Citation: BMC Cancer 2024 24:915
  35. Although there is a strong correlation between the novel cholesterol-to-lymphocyte ratio (CLR) and tumor survival, its prognostic significance in breast cancer (BC) is unknown. After analyzing the relationship...

    Authors: Li-Wen Wan, Chao Zhang, Yu-Ling Zhang, Fei Lin, Xin Hua and Wen Xia
    Citation: BMC Cancer 2024 24:914
  36. In China, the national cervical cancer screening protocol involves initial testing for high-risk human papillomavirus (hrHPV), followed by cytology for hrHPV-positive cases. This study evaluates the effectiven...

    Authors: Meiyuan Huang, Taoli Wang, Ming Li, Mei Qin, Shuang Deng and Dongliang Chen
    Citation: BMC Cancer 2024 24:913
  37. In oncology anti—PD1 / PDL1 therapy development for solid tumors, objective response rate (ORR) is commonly used clinical endpoint for early phase study decision making, while progression free survival (PFS) a...

    Authors: Lei Yang, Geethanjali Raveendran, Xiang Meng, Ji Lin and Zhaoling Meng
    Citation: BMC Cancer 2024 24:912
  38. Authors: Alexandra Leary, Purificación Estévez-García, Renaud Sabatier, Isabelle Ray-Coquard, Margarita Romeo, Pilar Barretina-Ginesta, Marta Gil-Martin, Elena Garralda, Joaquim Bosch-Barrera, Teresa Morán, Paloma Martin-Martorell, Ernest Nadal, Pere Gascón, Jordi Rodon, Jose M Lizcano, Pau Muñoz-Guardiola…
    Citation: BMC Cancer 2024 24:911

    The original article was published in BMC Cancer 2024 24:876

  39. A practical noninvasive method is needed to identify lymph node (LN) status in breast cancer patients diagnosed with a suspicious axillary lymph node (ALN) at ultrasound but a negative clinical physical examin...

    Authors: Xuefei Wang, Lunyiu Nie, Qingli Zhu, Zhichao Zuo, Guanmo Liu, Qiang Sun, Jidong Zhai and Jianchu Li
    Citation: BMC Cancer 2024 24:910
  40. Advancements in the diagnosis, treatment, and surveillance of castration-resistant prostate cancer (CRPC) have progressed considerably, but a new biomarker that combines existing clinical and pathological data...

    Authors: Jimin Lee, Jinhwa Hong, Ju Won Kim, Soonyoung Lim, Seung-Cheol Choi, Jeong-An Gim, Sung Gu Kang, Tae Il Noh and Kyong Hwa Park
    Citation: BMC Cancer 2024 24:909
  41. Estrogen receptors express in nearly 70% of breast cancers (ER-positive). Estrogen receptor alpha plays a fundamental role as a significant factor in breast cancer progression for the early selection of therap...

    Authors: Maedeh Raei, Keyvan Heydari, Mohammad Tabarestani, Alireza Razavi, Fatemeh Mirshafiei, Fatemeh Esmaeily, Mahsa Taheri, Aref Hoseini, Hojjatollah Nazari, Danial Shamshirian and Reza Alizadeh-Navaei
    Citation: BMC Cancer 2024 24:908
  42. This study aims to explore novel microRNAs in urine for screening and predicting clinical characteristics in pancreatic cancer (PC) patients using a microRNA array-based approach.

    Authors: Taisuke Imamura, Shuhei Komatsu, Keiji Nishibeppu, Jun Kiuchi, Takuma Ohashi, Hirotaka Konishi, Atsushi Shiozaki, Yusuke Yamamoto, Ryo Moriumura, Hisashi Ikoma, Toshiya Ochiai and Eigo Otsuji
    Citation: BMC Cancer 2024 24:907
  43. Prostate cancer (PCa) is a leading cause of cancer-related death in men. Understanding the proteomic landscape associated with PCa risk can provide insights into its molecular mechanisms and pave the way for p...

    Authors: Wenguo Sun, Haoming Li, Wenjie Shi, Quanlong Lv and Weili Zhang
    Citation: BMC Cancer 2024 24:905
  44. The lncRNA NEAT1 has been shown to promote the progression of several cancers, containing laryngeal squamous cell carcinoma (LSCC). However, the precise mechanism by which it promotes LSCC progression remains ...

    Authors: Jiwang Liang, Fengqin Fang, Xiaozhuo Gao, Ji Shi, Jian Zhao and Yuejiao Zhao
    Citation: BMC Cancer 2024 24:904
  45. Leukemia is a type of blood cell cancer that is in the bone marrow’s blood-forming cells. Two types of Leukemia are acute and chronic; acute enhances fast and chronic growth gradually which are further classif...

    Authors: Seher Ansar Khawaja, Muhammad Shoaib Farooq, Kashif Ishaq, Najah Alsubaie, Hanen Karamti, Elizabeth Caro Montero, Eduardo Silva Alvarado and Imran Ashraf
    Citation: BMC Cancer 2024 24:900

    The Correction to this article has been published in BMC Cancer 2024 24:981

  46. This study aimed to evaluate the efficiency of hippocampal avoidance whole-brain radiotherapy with a simultaneous integrated boost (HA-WBRT-SIB) treating brain metastases (BM) and utility of the Hopkins Verbal...

    Authors: Zhuoran Li, Jianyang Wang, Lei Deng, Yirui Zhai, Tao Zhang, Nan Bi, Jingbo Wang, Xin Wang, Wenyang Liu, Zefen Xiao, Dongfu Chen, Jima Lv, Qinfu Feng, Wenqing Wang and Zongmei Zhou
    Citation: BMC Cancer 2024 24:899

Featured videos

View featured videos from across the BMC-series journals